BVS / BRS trial updates and registries

Session comprising selected EuroPCR 2017 late-breaking trial submissions

Chairpersons: R. Waksman, J. Wykrzykowska

Presentations available when logged in:

  • Randomised comparison of everolimus-eluting bioresorbable vascular scaffolds vs. everolimus-eluting metallic stents in patients with coronary arter...
  • ABSORB Japan: 3-year clinical and angiographic results of a randomised trial evaluating the Absorb bioresorbable vascular scaffold vs. metallic DES...
  • Outcome of PCI with the Abbott everolimus-eluting BRS vs. modern DES: real life data from the Swedish coronary angiography and angioplasty registry...
  • Restenosis and its predictors after implantation of everolimus-eluting BRS: results from the GABI-R registry
  • Twelve-month results of an unrestricted use of bioresorbable vascular scaffolds in a real world coronary artery disease population: primary outcome...
  • The Absorb UK registry: one-year results of contemporary bioresorbable vascular scaffolds implantation
  • Primary endpoint of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS)
  • The France-Absorb registry: in-hospital and one-year follow-up results